Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Quest Diagnostics Inc (DGX) AI Forecast

Our AI detected a significant signal for Quest Diagnostics Inc. Create a free account to see the exact price target.

Free account • 30-day free trial

$DGX Bullish Signal Full forecast available

Quest Diagnostics Inc (DGX) Stock Forecast 2025


Quest Diagnostics Inc (DGX) AI Stock Price Forecast & Investment Analysis

Quest Diagnostics Inc Stock Price Chart and Technical Analysis

Loading chart...

Quest Diagnostics Inc (DGX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Quest Diagnostics Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 10, 2026, 11:02 a.m. (UTC)

Quest Diagnostics Inc Investment Summary

When evaluating whether Quest Diagnostics Inc (DGX) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Quest Diagnostics Inc (DGX) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry. The company employs approximately 25,064 people. With a market capitalization of $24 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Quest Diagnostics Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Quest Diagnostics Inc along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Quest Diagnostics Inc is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Quest Diagnostics Inc

Sign Up Free
Corporate Identity

Quest Diagnostics Inc (Stock Symbol: DGX) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Services-Medical Laboratories industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Quest Diagnostics Inc's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Quest Diagnostics Inc...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Quest Diagnostics Inc...

Unlock Full Company Profile

Get complete details about Quest Diagnostics Inc

Sign Up Free
Revenue & Growth Analysis

Quest Diagnostics Inc generates annual revenues of $11 billion , demonstrating substantial market presence and operational scale.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Quest Diagnostics Inc...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Quest Diagnostics Inc...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Quest Diagnostics Inc...

Unlock Financial Analysis

Get complete financial metrics for Quest Diagnostics Inc

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Quest Diagnostics Inc's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Quest Diagnostics Inc strategically competes in the highly dynamic Services-Medical Laboratories marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Quest Diagnostics Inc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company demonstrates exceptional operational efficiency through free cash flow generation of $2 billion annually , with year-over-year cash flow growth of 61.3%. This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.

Margin & Pricing Power Analysis

The company maintains a 38.2% gross margin reflecting moderate pricing power typical of many manufacturing, retail, or service businesses. While not exceptionally high, these margins provide adequate room for operating expenses and profit generation. Competitive pressures or cost increases could impact profitability if margins compress.

Operating margin of 20.9% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This strong operating margin indicates excellent cost control and efficient organizational structure relative to the revenue base.

Asset Utilization Efficiency

Asset turnover ratio of 0.78x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 1.46 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.

Quest Diagnostics Inc (DGX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Quest Diagnostics Inc stock analysis.

Deep dive into Quest Diagnostics Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Quest Diagnostics Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Quest Diagnostics Inc: With a P/E ratio of 23.71, the market moderately values the company's earnings.

P/E Ratio 23.71x
P/B Ratio 3.28x
Market Cap $23.52B
Dividend Yield 0.43%
EPS $8.64
Book Value/Share $64.59
Revenue/Share $99.41
FCF/Share $10.18
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Quest Diagnostics Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Quest Diagnostics Inc: An ROE of 28.6% demonstrates excellent shareholder value creation.

ROE 28.6%
ROA 13.7%
ROIC 17.7%
Gross Margin 38.2%
Operating Margin 20.9%
Net Margin 17.6%
EBT Margin 22.7%
Tax Rate 22.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Quest Diagnostics Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Quest Diagnostics Inc: A current ratio of 1.46 shows adequate liquidity.

Current Ratio 1.46x
Quick Ratio 1.23x
D/E Ratio 0.71x
Financial Leverage 2.11x
Interest Coverage 17.1x
Working Capital $1.28B
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Quest Diagnostics Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Quest Diagnostics Inc: Free cash flow of $1602M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $1.98B
Free Cash Flow $1.60B
Capital Spending -$380M
OCF Growth YoY 61.3%
FCF Growth YoY 88.3%
FCF/Sales 15.0%
CapEx/Sales 3.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Quest Diagnostics Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Quest Diagnostics Inc: An asset turnover of 0.78x suggests room for improvement in asset utilization.

Asset Turnover 0.78x
Receivables Turnover 7.8x
Inventory Turnover 31.4x
Fixed Assets Turnover 4.7x
Days Sales Outstanding 47 days
Days Inventory 12 days
Payables Period 22 days
Cash Conversion Cycle 40 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Quest Diagnostics Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Quest Diagnostics Inc: With annual revenue of $11035M, Quest Diagnostics Inc operates at significant scale.

Income Statement
Total Revenue $11.04B
SG&A Expense $16M
Cost of Goods Sold $62M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 18%
Cash & Short-term Investments 5%
Total Liabilities 52%
Short-term Debt 0%
Accounts Receivable 10%
Inventory 1%
Dividend & Shareholder Information
Dividends Per Share $0.80
Shares Outstanding 111M
Growth Metrics (YoY)
EPS Growth 4.6%

Latest Quest Diagnostics Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Quest Diagnostics Inc (DGX) stock price and investment outlook.

📰 We are currently updating our news feed for Quest Diagnostics Inc. Check back soon for the latest market analysis and company updates.

Quest Diagnostics Inc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Quest Diagnostics Inc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aclarion, Inc. ACON ██% $3M 0.0x 0.3x
Advanced Biomed Inc. ADVB ██% $7M 1.0x 0.7x
American Shared Hospital Services AMS ██% $14M 5.2x 0.6x
Biodesix Inc BDSX ██% $160M -3.0x 140.7x
Bionexus Gene Lab Corp BGLC ██% $5M x 0.8x
Burning Rock Biotech Ltd BNR ██% $0.00M x 0.0x
Caris Life Sciences, Inc. CAI ██% $5.37B 50.5x 9.3x
Caredx, Inc. CDNA ██% $903M 16.5x 3.0x
Celcuity Inc. CELC ██% $4.91B -4.5x 42.0x
Castle Biosciences Inc CSTL ██% $802M -2110.5x 1.7x
Quest Diagnostics Inc DGX ██% $23.52B 23.7x 3.3x
Exact Sciences Corp EXAS ██% $19.75B -343.6x 8.2x
First Choice Healthcare Solutions, Inc. FCHS ██% $130K x 0.0x
Fulgent Genetics, Inc. FLGT ██% $455M 516.8x 0.4x
Fortrea Holdings Inc. FTRE ██% $915M -6.8x 1.6x
Guardant Health, Inc. GH ██% $11.91B -8.9x 174.5x
Grail, Inc. GRAL ██% $2.01B x 0.9x
Labcorp Holdings Inc. LH ██% $22.17B 25.3x 2.6x
Ludwig Enterprises, Inc. LUDG ██% $6M x x
Mdxhealth Sa MDXH ██% $162M x x
Natera, Inc. NTRA ██% $27.68B -74.2x 16.2x
Capforce Inc. OPGN ██% $242M x 23.8x
Psychemedics Corp PMDI ██% $9M x 1.8x
Personalis, Inc. PSNL ██% $696M -2.3x 2.7x
Radnet, Inc. RDNT ██% $4.49B 462.8x 4.1x
Renalytix Plc RENXF ██% $13M x x
Renalytix Plc RNLXY ██% $511M x 73.4x
Sera Prognostics, Inc. SERA ██% $88M -9.0x 1.1x
Veracyte, Inc. VCYT ██% $2.69B 40.5x 2.1x
Exagen Inc. XGN ██% $74M -5.4x 4.1x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Quest Diagnostics Inc Stock Forecast

How accurate are Quest Diagnostics Inc stock predictions?

Our AI model shows a -6% Spearman correlation coefficient for DGX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Quest Diagnostics Inc stock price forecasts?

Our analysis considers Quest Diagnostics Inc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Quest Diagnostics Inc a good investment in 2025?

Based on our AI analysis, Quest Diagnostics Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Quest Diagnostics Inc forecasts updated?

Quest Diagnostics Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...